Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis (Q31143319)

29 June 2017

1 reference

title

Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis (English)

1 reference

29 June 2017

1 reference

1 reference

David Burgner

0 references

Jane W Newburger

1 reference

29 June 2017

Jan Bonhoeffer

1 reference

29 June 2017

Karina A Top

1 reference

29 June 2017

Rolando Ulloa-Gutierrez

object named as

Rolando Ulloa-Gutierrez

1 reference

29 June 2017

Jim Buttery

1 reference

29 June 2017

Linny Kimly Phuong

1 reference

29 June 2017

Caterina Bonetto

1 reference

29 June 2017

Yolanda Brauchli Pernus

object named as

Yolanda Brauchli Pernus

1 reference

29 June 2017

Merita Kucuku

1 reference

29 June 2017

Frederick Varricchio

1 reference

29 June 2017

Karen L Goldenthal

1 reference

29 June 2017

Sarah de Ferranti

1 reference

29 June 2017

Rebecca Chandler

1 reference

29 June 2017

Giuseppe Monaco

1 reference

29 June 2017

Barbara Pahud

1 reference

29 June 2017

Stanford T Shulman

1 reference

29 June 2017

Nagib Dahdah

1 reference

29 June 2017

Surjit Singh

1 reference

29 June 2017

Brighton Collaboration Kawasaki Disease (KD) Working Group

1 reference

29 June 2017

language of work or name

English

0 references

publication date

15 November 2016

1 reference

29 June 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

29 June 2017

1 reference

29 June 2017

1 reference

29 June 2017

page(s)

6582-6596

1 reference

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease: A brief history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The epidemiology of Kawasaki disease: a global update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki Syndrome-Like Illness Associated with Infection Caused by Enterotoxin B-Secreting Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The development of standardized case definitions and guidelines for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Vasculitis as an adverse event following immunization - Systematic literature review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Diagnosis of incomplete Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Positive hepatitis serologies with treatment for Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease: review of risk factors for coronary aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary risks after high-dose gamma-globulin in children with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Incomplete Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease without fever in a Costa Rican girl: first report from Central America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease without fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease in a young adult with a perineal rash

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Recurrent toxin-mediated perineal erythema: eleven pediatric cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Recurrent toxin-mediated perineal erythema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Clinical Implication of the C Allele of the ITPKC Gene SNP rs28493229 in Kawasaki Disease: Association With Disease Susceptibility and BCG Scar Reactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Presence in Kawasaki Disease of Antibodies to Mycobacterial Heat-Shock Protein HSP65 and Autoantibodies to Epitopes of Human HSP65 Cognate Antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Pathogenesis of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

How to image Kawasaki disease: a validation of different imaging techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary artery outcomes among children with Kawasaki disease in the United States and Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The use of Z-scores in paediatric cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary artery dimensions in febrile children without Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Widened coronary arteries in a feverish child.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with Fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Assessment of coronary artery lesions in children with Kawasaki disease: evaluation of MSCT in comparison with 2-D echocardiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The value of angiography in the follow-up of coronary involvement in mucocutaneous lymph node syndrome (Kawasaki disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Echocardiography and coronary CT angiography imaging of variations in coronary anatomy and coronary abnormalities in athletic children: detection of coronary abnormalities that create a risk for sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Diagnoses and Surgical Results in 12 Pediatric Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Echocardiographic findings in fulminant and acute myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Sedation/anaesthesia in paediatric radiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Giant coronary artery aneurysms in Kawasaki's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Long-term follow up of abdominal aortic aneurysm complicating Kawasaki disease: comparison of the effectiveness of different imaging methods

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Exercise myocardial perfusion imaging to evaluate inducible ischaemia in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Usefulness of echocardiography for detection of coronary artery thrombi in patients with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Comparison of macroscopic, postmortem, angiographic and two-dimensional echocardiographic findings of coronary aneurysms in children with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Acute surgical abdomen as presenting manifestation of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

The surgical manifestations of the intestinal tract in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Early but prolonged gallbladder hydrops in a 7-month-old girl with Kawasaki syndrome: Report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Gall bladder hydrops - a rare initial presentation of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Hydrops of the gallbladder associated with Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki disease mimicking an acute appendicitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Kawasaki syndrome: report of four cases with acute gallbladder hydrops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Evolution of Laboratory Values in Patients With Kawasaki Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Acute-Phase Reactants and a Supplemental Diagnostic Aid for Kawasaki Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Do predictors of incomplete Kawasaki disease exist for infants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Use of intravenous immunoglobulin G (IVIG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Intravenous polyclonal immunoglobulin administration to sepsis syndrome patients: a prospective study in a pediatric intensive care unit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Intravenous γ-Globulin Treatment in Kawasaki Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.025

10.1016/J.VACCINE.2016.09.025

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference